| Literature DB >> 20298983 |
Nabil Dib1, Philippe Menasche, Jozef J Bartunek, Andreas M Zeiher, Andre Terzic, Nicolas A Chronos, Timothy D Henry, Nicholas S Peters, Francisco Fernández-Avilés, Magdi Yacoub, Timothy A Sanborn, Anthony Demaria, Richard A Schatz, Doris A Taylor, Shmuel Fuchs, Silviu Itescu, Leslie W Miller, Jonathan H Dinsmore, George D Dangas, Jeffrey J Popma, Jennifer L Hall, David R Holmes.
Abstract
The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.Entities:
Mesh：
Year: 2010 PMID： 20298983 DOI： 10.1016/j.jcin.2009.12.013
Source DB: PubMed Journal: JACC Cardiovasc Interv ISSN： 1936-8798 Impact factor: 11.195